LLY

995.84

-1.3%↓

JNJ

201.6

-0.09%↓

ABBV

222.95

-1.45%↓

UNH

323.16

-2.22%↓

AZN

91.2

+1.13%↑

LLY

995.84

-1.3%↓

JNJ

201.6

-0.09%↓

ABBV

222.95

-1.45%↓

UNH

323.16

-2.22%↓

AZN

91.2

+1.13%↑

LLY

995.84

-1.3%↓

JNJ

201.6

-0.09%↓

ABBV

222.95

-1.45%↓

UNH

323.16

-2.22%↓

AZN

91.2

+1.13%↑

LLY

995.84

-1.3%↓

JNJ

201.6

-0.09%↓

ABBV

222.95

-1.45%↓

UNH

323.16

-2.22%↓

AZN

91.2

+1.13%↑

LLY

995.84

-1.3%↓

JNJ

201.6

-0.09%↓

ABBV

222.95

-1.45%↓

UNH

323.16

-2.22%↓

AZN

91.2

+1.13%↑

Начало・Списък с акции・Amicus Therapeutics Inc

Amicus Therapeutics Inc

Затворен

СекторЗдравеопазване

9.82 -0.81

Купи Продай

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

9.73

Максимум

9.96

Ключови измерители
By Trading Economics
Приходи	42M 17M
Продажби	14M 169M
EPS	0.17
Марж на печалбата	10.237
Служители	499
EBITDA	54M 48M

Препоръки
By TipRanks
Препоръки	Силна покупка
12-месечна прогноза	+60.4% upside

Пазарни показатели
By TradingEconomics
Пазарна капитализация	678M 3B
Предишно отваряне	10.63
Предишно затваряне	9.82

Настроения в новините

By Acuity

39%

61%

128 / 374 Класиране в Healthcare

Техническа оценка

By Trading Central

Увереност

Very Strong Bearish Evidence

5.925 / 7.38 Подкрепа & съпротива

Amicus Therapeutics Inc Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

8.12.2025 г., 23:48 ч. UTC

Значими двигатели на пазара

Shares of Sezzle and Vital Farms Rise on S&P SmallCap 600 Inclusion

8.12.2025 г., 23:44 ч. UTC

Пазарно говорене

Perky Australian Dollar Looks to Extend Gains -- Market Talk

8.12.2025 г., 23:42 ч. UTC

Пазарно говорене

Nikkei May Decline Amid Uncertainty Over Econ, Earnings -- Market Talk

8.12.2025 г., 23:13 ч. UTC

Пазарно говорене

Global Forex and Fixed Income Roundup: Market Talk

8.12.2025 г., 23:13 ч. UTC

Пазарно говорене

Australian Inflation Expectations Highest Since Late 2023 -- Market Talk

8.12.2025 г., 23:09 ч. UTC

Придобивния, сливания и поглъщания

Paramount Made a Hostile Bid for Warner After Netflix Deal. What Happens Next? -- WSJ

8.12.2025 г., 22:46 ч. UTC

Пазарно говорене

Rio Tinto Building Low-Cost Lithium Business in Difficult Market -- Market Talk

8.12.2025 г., 22:01 ч. UTC

Пазарно говорене

Miners Poised to Do Well in 2026 -- Market Talk

8.12.2025 г., 22:00 ч. UTC

Придобивния, сливания и поглъщания

Noble: Agreement With Borr Includes Sale of Noble Tom Prosser, Noble Mick O'Brien, Noble Regina Allen, Noble Resilient, Noble Resolute, Closing Expected in Early 2026 >NE

8.12.2025 г., 22:00 ч. UTC

Придобивния, сливания и поглъщания

Noble: Agreement With Borr Comprises $210M in Cash and $150M in Seller Notes >NE

8.12.2025 г., 22:00 ч. UTC

Придобивния, сливания и поглъщания

Noble: Agreement With Ocean Oilfield Drilling Anticipates the Sale of the Noble Resolve, Closing Is Expected in 2Q 2026, Upon Conclusion of Noble Resolve's Current Contract >NE

8.12.2025 г., 22:00 ч. UTC

Придобивния, сливания и поглъщания

Noble: To Sell Five Rigs to Borr Drilling Limited for $360M and One Rig to Ocean Oilfield Drilling for $64M in Cash >NE

8.12.2025 г., 21:51 ч. UTC

Пазарно говорене

US-Canada Rate Spreads Narrow Sharply After Record Gap -- Market Talk

8.12.2025 г., 21:50 ч. UTC

Пазарно говорене

Придобивния, сливания и поглъщания

Tech, Media & Telecom Roundup: Market Talk

8.12.2025 г., 21:50 ч. UTC

Пазарно говорене

Auto & Transport Roundup: Market Talk

8.12.2025 г., 21:50 ч. UTC

Пазарно говорене

Basic Materials Roundup: Market Talk

8.12.2025 г., 21:38 ч. UTC

Придобивния, сливания и поглъщания

Boeing Buys Company Responsible for Door Blowout. The Stock Rises. -- Barrons.com

8.12.2025 г., 21:38 ч. UTC

Придобивния, сливания и поглъщания

Paramount Makes $77.9 Billion Hostile Bid for Warner After Netflix Struck Deal -- 7th Update

8.12.2025 г., 21:36 ч. UTC

Пазарно говорене

Oil Oversupply to Show Up As Waterborne Stocks Land -- Market Talk

8.12.2025 г., 21:20 ч. UTC

Придобивния, сливания и поглъщания

Will the Netflix-Warner Bros. Merger Go Through? It Depends on How You Define Market Share. -- Barrons.com

8.12.2025 г., 21:12 ч. UTC

Придобивния, сливания и поглъщания

These Stocks Moved the Most Today: Warner Bros., Paramount, Netflix, Tesla, CoreWeave, Confluent, Marvell, Carvana, and More -- Barrons.com

8.12.2025 г., 21:08 ч. UTC

Пазарно говорене

Rosenberg Turns 'Outright Bullish' on Canada Dollar -- Market Talk

8.12.2025 г., 20:38 ч. UTC

Пазарно говорене

Придобивния, сливания и поглъщания

Netflix Co-CEOs Confident About Regulatory Approval for WBD Deal -- Market Talk

8.12.2025 г., 20:26 ч. UTC

Придобивния, сливания и поглъщания

These Stocks Are Moving the Most Today: Warner Bros., Paramount, Netflix, Tesla, CoreWeave, Confluent, Marvell, Carvana, and More -- Barrons.com

8.12.2025 г., 20:18 ч. UTC

Пазарно говорене

Придобивния, сливания и поглъщания

Netflix Isn't Looking to Make Cuts at Warner Bros. Discovery -- Market Talk

8.12.2025 г., 20:07 ч. UTC

Пазарно говорене

Oil Futures Snap Three-Session Winning Streak -- Market Talk

8.12.2025 г., 20:06 ч. UTC

Пазарно говорене

U.S. Natural Gas Pulls Back From Weather-Driven Highs -- Market Talk

8.12.2025 г., 20:05 ч. UTC

Пазарно говорене

Global Equities Roundup: Market Talk

8.12.2025 г., 20:05 ч. UTC

Пазарно говорене

Deere Offers Sales Growth Forecast Through 2030 -- Market Talk

8.12.2025 г., 20:01 ч. UTC

Пазарно говорене

Precious Metals Slip Ahead of Fed Decision -- Market Talk

Сравнение с други в отрасъла

Ценова промяна

Amicus Therapeutics Inc Прогноза

Ценова цел

By TipRanks

60.4% нагоре

12-месечна прогноза

Среден 15.88 USD 60.4%

Висок 21 USD

Нисък 11 USD

Според 8 анализатори от Wall Street, предложили 12-месечна ценова цел за Amicus Therapeutics Inc през последните три месеца.

Консенсусна оценка

By TipRanks

Силна покупка

8 ratings

Купи

Задържане

Продай

Според 8 анализатори, дали борсови рейтинги на Amicus Therapeutics Inc през последните 3 месеца.

Техническа оценка

By Trading Central

5.925 / 7.38Подкрепа & съпротива

Recent bearish events outweigh bullish events.

Recent bullish events outweigh bearish events.

All events are bearish.

Настроение

By Acuity

128 / 374 Класиране в Здравеопазване

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

Относно Amicus Therapeutics Inc

Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant; and Pombiliti + Opfolda, for the treatment of late onset. It has collaboration and license agreements with the University of Pennsylvania to research and develop parvovirus gene therapy products; and GlaxoSmithKline. Amicus Therapeutics, Inc. was incorporated in 2002 and is headquartered in Princeton, New Jersey.